Thanks hottod once again for some interesting insight.I'm...

First 3980 Last

Share
Profile

Follow
cableguy1411

465 Posts.

76

09/03/23

11:45

Post #: 66674953
Share

Originally posted by hottod: ↑

It was suggested by a poster yesterday that most drugs that have their marketing decisions go down to the wire at the FDA are rejected or delayed.

I thought I’d examine the evidence for this. Due to time constraints, I limited my enquiry to orphan drug marketing approval decisions made by the FDA in the first quarter of last year, as listed here.

Findings

There were 10 orphan drugs with assigned PDUDA dates in Q1 last year.

Half (5) of the decisions were announced on the assigned PDUFA date. Of these, 2 were approvals and 3 were CRLs. Of the CRLs received on the PDUFA date, one was for Reata Pharmaceuticals’ drug, bardoxolone. Last month, Reata again had to wait until the PDUFA date for a decision on another drug, omaveloxolone. This time, it received an approval.

Four received early replies. Two were approvals, one was a CRL and one was a decision to extend the PDUFA date.

One decision was late (by 3 days). It was an approval.

Hence, of the 5 approvals, 2 were early, 2 were on PDUFA and 1 was late.

Of the 5 non-approvals, 2 were early, 3 were on PDUFA and none was late.

Limited data obviously but certainly not suggestive that going down to the wire is mostly associated with rejection or delay.

Expand

Thanks hottod once again for some interesting insight.
I'm hoping the FDA are late in responding because none of the one's considered by hottod that failed were late.

NEU Price at posting: $7.82 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

KGL

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

IDA

Indiana Resources to win US$90M from Tanzania following international lawsuit

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

BC8

Black Cat Syndicate one pour away from being rerated as producer

There are more pages in this discussion • 6,976 more messages in this thread...

First 3980 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $20.07		Change -0.105(0.52%)		Mkt cap ! $2.576B

Open	High	Low	Value	Volume
$20.45	$20.45	$20.06	$335.8K	16.58K

Buyers (Bids)

No.	Vol.	Price($)
5	244	$20.04

Sellers (Offers)

Price($)	Vol.	No.
$20.07	48	3

View Market Depth

No.	Vol.	Price($)
6	82	20.100
2	16	20.090
3	180	20.080
2	169	20.070
5	420	20.060

Price($)	Vol.	No.
20.130	228	9
20.140	308	4
20.150	258	6
20.160	446	5
20.170	358	4

Last trade - 11.09am 29/07/2024 (20 minute delay)

NEU (ASX) Chart

Thanks hottod once again for some interesting insight.I'm...

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Indiana Resources to win US$90M from Tanzania following international lawsuit

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Black Cat Syndicate one pour away from being rerated as producer

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks hottod once again for some interesting insight.I&apos;m...

Top Stories

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Indiana Resources to win US$90M from Tanzania following international lawsuit

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Black Cat Syndicate one pour away from being rerated as producer

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks hottod once again for some interesting insight.I'm...